-
2024-514952-34-00
5
2023-06-23
Catheter related bloodstream infections due to Staphylococcus aureus
-
2022-501710-62-02
6
2023-06-07
Peripheral T-cell lymphoma (PTCL)
-
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
-
2024-511001-28-00
4
2021-12-13
Neuroendocrine tumor
-
2024-516181-11-00
4
2021-06-10
RELAPSE/REFRACTORY B-CELL LYMPHOMA.
-
2024-514603-34-00
5
2020-03-02
intermediate-risk differentiated thyroid cancer patients
-
2024-518578-15-00
5
2018-02-05
Is to demonstrate a non inferior efficacy of azithromycin and so the p
-
2024-512147-23-00
10
2024-11-21
Chronic Lymphocytic Leukemia
-
2023-507851-31-00
5
2024-09-23
Immunoglobulin A Nephropathy (IgAN)
-
2023-504176-25-00
9
2024-08-08
Acute Myeloid Leukemia
-
2023-505972-32-00
5
2024-02-26
locally advanced anal squamous cell carcinoma
-
2024-515479-36-00
5
2023-07-05
Chronic Myeloid Leukemia
-
2024-514480-26-00
4
2022-10-12
Post-menopausal women with localized luminal A breast cancer and consi
-
2023-505807-21-00
5
2021-11-16
Relapsed/refractory follicular lymphoma
-
2024-516651-41-00
5
2021-10-08
COPD : chronic obstructive Pulmonary disease
-
2024-513252-15-00
4
2021-01-28
IN RELAPSED/REFRACTORY PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA
-
2024-513005-31-00
5
2020-06-11
Patients with untreated metastatic Estrogen Receptor positive (ER+), H
-
2024-514829-36-00
5
2019-12-02
High-risk biochemically-relapsed prostate adenocarcinoma following rad
-
2024-514088-25-00
5
2019-10-07
Multiple Myeloma
-
2024-518836-36-00
5
2019-10-07
Respiratory Distress Syndrome of preterm babies born < 32 weeks of ges
-
2024-515946-17-00
5
2019-07-22
Non Small Cell Lung Cancer
-
2024-516048-24-00
4
2019-06-19
CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST
-
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia
-
2024-513206-65-00
5
2018-08-10
resected squamous cell carcinoma of head and neck